No Data
No Data
Scinai Signs $10M Standby Equity Agreement, Retains Control Over Stock Sales to Yorkville
Press Release: SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
Scinai Immunotherapeutics Files to Sell 3.02M ADS for Holders
Scinai to Connect With Investors and Pharma Leaders at Upcoming Key US Conferences
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Express News | Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services
Unlock the Full List